Type in Biological Technology
Navigation Links
Type in Biological Technology
Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress
... quarter of 2008. Product revenue from the Onco type DX(R) breast cancer test was $35.2 million in ... increased total cash, in part by expanding Onco type DX access and coverage to a broader breast ... of cancer. Since 2004, we have delivered Onco type DX to more than 100,000 breast cancer patients ...... fill and finish of purified human recombinant type VII collagen. The recombinant protein will be ... born with defects in the gene that encodes type VII collagen. DEB is characterized by extremely ... for the study. Clinical manufacturing of type VII collagen and related research and development ...
... study of its oral insulin capsule, ORMD-0801, on type 1 diabetic patients. The completion of this study ... Oramed's first clinical trial on patients with type 1 Diabetes Mellitus, whereas, all Oramed's trials up to date have been conducted on type 2 diabetic patients. This study evaluated safety, ...
... enables greater than 90 percent purity of any type of cells. Secondly, the Field patents cover the ... to identify and select a particular cell type (e.g. heart cells) and produce a highly purified ... and their ability to differentiate into any cell type for world-class drug development tools. In ...
... risk of several medical conditions including type 2 diabetes, non-alcoholic fatty liver disease, ... that approximately two-thirds of patients with type 2 diabetes are overweight or obese, with a BMI ... individuals with BMI less than 35 kg/m2 without type 2 diabetes have dyslipidemia and/or hypertension. ...
Researchers enlist DNA to bring carbon nanotubes' promise closer to reality
... single-chirality species of the same electronic type from a synthetic mixture of single-walled ... sequence correctly, it recognizes a particular type of CNT and enables us to sort that variety ... palm and out to your little finger, you form a type of beta sheet. "Such a structure is not known ...New Drug Application for Exenatide Once Weekly Accepted for Review by FDA
... investigational sustained release medication for type 2 diabetes that is injected subcutaneously and ... and in many countries worldwide for people with type 2 diabetes who are unable to achieve good ... development program and in the treatment of type 2 diabetes," said Orville G. Kolterman, M.D., ...New Report Just Published: World Prostate Cancer Therapeutics Market Report
... Cancer Survival Rate Among US Males by type - Prostate and Testis (1996-2002) (includes ... the US (2007): Percentage Breakdown by Cancer type - Lung & Bronchus, Prostate, Colon & ... Among African Americans and Whites by Cancer type in the US, 2000- 2004 (includes corresponding ...It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer
... risk of heart attack and others have linked to type 2 diabetes. deCODE used its population genetics ... laboratory, deCODE offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation ... prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer, for the ...... that validated multigene assays, such as Onco type DX(R), should be considered as an adjunct to ... obtained from multigene assays, including Onco type DX, leads to a change in treatment decisions in ... from more than 40 countries currently use Onco type DX to predict the likelihood of chemotherapy ...
Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply
... a booster dose of Haemophilus influenzae type b (Hib) vaccine after 12 months of age. The CDC ... About Hib Disease Haemophilus influenzae type b, or Hib, is a bacterium that resides in the ... invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use in ...Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials
... Phase IIb clinical trial in 494 patients with type 2 diabetes mellitus (T2DM), 'Melogliptin', ... improved glycemic control in patients with type 2 diabetes mellitus and exhibited excellent ... anti-diabetic therapies in patients with type 2 diabetes mellitus". said Mr. Glenn Saldanha, MD ...Spherix Announces Termination of Arla License Agreement
... as a novel pharmaceutical treatment for type 2 diabetes. Spherix is very satisfied with the ... investigating Naturlose as a treatment for type 2 diabetes in a Phase 3 clinical trial. The ... without any restriction on usages. About type 2 Diabetes ...Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
... Current Phase 3 Trial of Naturlose(R) for type 2 Diabetes BETHESDA, Md., June 23 ... and safety of Naturlose as a treatment for type 2 diabetes. "Receiving this delivery of ... Naturlose as a novel and natural option to treat type 2 diabetes." Inalco, a global ...... delivery of exenatide) for the treatment of type 2 diabetes as a late-breaker at the Annual ... to deliver exenatide therapy for the treatment of type 2 diabetes," said K. Alice Leung, President & ... a 28-day course of ITCA 650 treatment among 44 type 2 diabetes patients (10-12 patients/dose arm) on ...
Diamyd(R) Phase III Study Approved for Younger Patients in the US
... (FDA) to include children with type 1 diabetes from 10 years of age in the company's ... in children and adolescents with recent-onset type 1 diabetes. The European study, which is ... to 20 years, an age group with few recent-onset type 1 diabetes patients. The company is, with the new ...Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
... loss and the corresponding positive impact on type 2 diabetes. Data from the phase 3 EQUATE trial ... weight loss with Qnexa stops the progression of type 2 diabetes in obese, non-diabetic patients. The ... with Qnexa can significantly lower blood sugar in type 2 diabetics. "Obesity ...Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management
... diseases (with a primary focus on type 2 diabetes) from Research to Phase 2 Clinical ... achieved its clinical proof-of-concept for the type 2 diabetes monotherapy indication- and other ... Serono is shareholders of Poxel. About type 2 Diabetes: ...... delivery of exenatide for the treatment of type 2 diabetes HAYWARD, Calif., May 27 ... delivery of exenatide) for the treatment of type 2 diabetes as a late-breaker at the Annual ... 44 patients (n= 10-12 patients/dose arm) with type 2 diabetes. (Logo: ...
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
... risk of heart attack regardless of heart-attack type (procedural related or spontaneous), size or ... types of heart attacks based on the size and type of heart attack.(3) The types of heart attacks ... to the definition, included: type 1: Spontaneous heart attack caused by a primary ...A New Era in the Application of Lab-on-a-Chip to Rapid Point-of-Care Diagnosis
... portfolio: a Diagnostic Test Kit for Influenza type A/H1N1 and a MOBILE FIELD UNIT ensuring ... stable under varying ambient conditions. type A/H1N1 detection kits are available across three ... EFADchip , Diagnostic Test Kit for Influenza type A/H1N1 and MOBILE FIELD UNIT visit ....Lilly Set to Unveil More Than 50 Studies at ASCO 2009
... non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell. ALIMTA is ... non-small cell lung cancer (NSCLC), a specific type of NSCLC, after prior chemotherapy. ALIMTA is not ...New Danish research shows how oil gets stuck underground
... of the North Sea are primarily chalk the same type of rock that the cliffs of Stevns and Mns in ... is the first time that investigations of this type have been carried out on chalk from an oil field ... of ancient algae. The algae gave their cases a type of "surface coating" to make them resistant to ...Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes
... investigational sustained release medication for type 2 diabetes that is injected subcutaneously and ... and in many countries worldwide for people with type 2 diabetes who are unable to achieve good ... weekly to significantly advance the treatment of type 2 diabetes," said Daniel M. Bradbury, president ...Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
... of Phase 3 clinical development of Syncria in type 2 diabetes. In addition, we made solid financial ... (albiglutide) in the long-term treatment of type 2 diabetes mellitus. Syncria was created by HGS ... Phase 3 development as a potential treatment for type 2 diabetes. For more information about HGS, ...deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
... attack, stroke, atrial fibrillation (AF) and type 2 diabetes (T2D). These markers can be ... important genetic risk factor yet found for type 2 diabetes(4). Testing individuals with ... deCODE is offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation ...... with commercialization plans to make the Onco type DX colon cancer Recurrence Score available to ... assay technology designed for the company's Onco type DX breast cancer assay. More than 1,800 colon ... clinical studies to select the genes for the Onco type DX colon cancer assay. The resulting genes were ...
Spherix Announces 2008 Financial Results
... trial investigating efficacy as a treatment for type 2 diabetes continues on schedule; completion ... efficacy of Naturlose as a novel treatment for type 2 diabetes. I am pleased to report that Spherix ... to study the use of Naturlose as a treatment for type 2 diabetes. Its Spherix Consulting subsidiary ...Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
... guidance for evaluating cardiovascular risk in type 2 diabetes agents. Results of this analysis ... morbidity and mortality associated with type 2 diabetes," commented Professor Holman. "This ... to become the first weekly therapy to treat type 2 diabetes with glucose control and weight loss. ...... Resources' Clinical Gold Standard Status for type 2 Diabetes in 2012, According to a New Report ... most influences their prescribing decisions in type 2 diabetes. Clinical data and the opinions of ... in the market. The new report entitled type 2 Diabetes: Endocrinologists' Satisfaction with ...
MannKind Submits NDA for AFRESA for Treatment of Diabetes
... Inhaler for the treatment of adults with type 1 or type 2 diabetes mellitus for the control of ... 5,300 patients. More than 2,450 subjects with type 1 ...Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe
... Therapy E valuation F or E arly or N ew Onset type 1 D iabetes), the Phase 3 trial of otelixizumab, ... has begun enrollment of new onset autoimmune type 1 diabetes patients in Europe. In DEFEND, ... development of innovative immune intervention for type 1 diabetes patients. We have begun dosing ...Assembling cells into artificial 3-D microtissues, including a tiny gland
... of the National Academy of Sciences . One type of cell that needs other cells to make it work ... into all of this, and you need more than one cell type to achieve such regulation." "If you really ... to a lymph node, for example such that one cell type secreted interleukin-3 and thereby kept a second ...FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
... in adults and children (4 years and older) with type 1 diabetes or adults with type 2 diabetes. The approval of Apidra(R) ... in adults and children (4 years and older) with type 1 diabetes and adults ...Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug
... - Isis' first kidney-targeted antisense drug for type 2 diabetes enters clinical development ... of sodium dependent glucose co-transporter type 2 (SGLT2). SGLT2 is the major transporter ... of the antisense drug ISIS-SGLT2Rx to treat type 2 diabetes. Any statement describing Isis' ...Novel Diabetes Drug Discovery Has Potential to Reverse Disease
... breaking discovery with the potential to reverse type 1 and 2 diabetes. Scientists at CureDM, Inc. ... diagnosis, islet mass is often reduced by 80% in type 1 patients and 50% in type 2 patients, supporting the importance of islet ...Tips from the journals of the American Society for Microbiology
... infectivity of human rotavirus, adenovirus type 5, poliovirus type 1, and norovirus, as well as feline calicivirus and murine norovirus type 1 from the new ethanol-based sanitizer. ...University of Minnesota Receives $40 Million for Type 1 Diabetes Research
... translate it into a viable cure for people with type 1 diabetes. The gift is the second ... of the Schulze Diabetes Institute. "Curing type 1 diabetes is possible. We only need to declare ... a sense of urgency and responsibility." type 1 diabetes is a crippling and relentless disease. ...... with increased fasting glucose levels and risk of type 2 diabetes (T2D). deCODE will employ its ... them at more than 15 percent greater risk of type 2 diabetes than individuals who carry no copies. ... that underpin glucose regulation and risk of type 2 diabetes. This variant does not confer ...
Tips from the journals of the American Society for Microbiology
... infectivity of human rotavirus, adenovirus type 5, poliovirus type 1, and norovirus, as well as feline calicivirus and murine norovirus type 1 from the new ethanol-based sanitizer. ...Other ContentsorganizerorganizerorganizerobjectiveobjectiveobjectiveobjectiveobjectiveobjectiveobjectiveobjectiveobjectiveocularocularocularocularocularfragmentsfragmentsfragmentsfragmentsfragmentsfragmentsfragmentsfragmentsoffspringoffspringoffspringoffspringoffspringOther TagsPEGUCOMUCOMDonorsOther Tagsdevelopers 2neuronal 2neuronal 3neuronal 4neuronal 5neuronal 6hold 2hold 3hold 4hold 5hold 6hold 7hold 8hold 9hold 10zebrafish 2special 2special 3special 4special 5special 6special 7special 8special 9special 10very 2very 3very 4very 5very 6very 7very 8very 9very 10
(Date:12/4/2009)... with one another for space and dominance. Though the manner ... to be the survival of the fittest, how stem cells ... clear. A study on fruit flies published in the October ... describes how stem cells win this battle by literally sticking ...
(Date:12/4/2009)... is widely used by physicians and scientists to study ... has remained largely unknown whether the electrodes on the ... inside the brain. Scientists at the Max Planck Institute ... a crucial link between the activity generated within the ...
(Date:12/3/2009)... Hausen and his co-workers discovered that specific types of ... out how these pathogens cause cells to degenerate. It ... proteins E6 and E7. Both proteins switch off different ... Professor Dr. Frank Rsl and his co-workers at DKFZ ...
Breaking Biology News(10 mins):Stem cells battle for space 2How to read brain activity? 2Papillomavirus silences innate immune response 2Natural Pepper Skin Sprays Stop Any Itch In Minutes Without Burning 60740 1Natural Pepper Skin Sprays Stop Any Itch In Minutes Without Burning 60740 2Natural Pepper Skin Sprays Stop Any Itch In Minutes Without Burning 60740 3Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 1Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 2Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 3Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 4Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 5Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 6Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 7Regences Social Media Web Site Gets a Facelift 60731 1Regences Social Media Web Site Gets a Facelift 60731 2(Date:12/6/2009)... Fox, LLP says dangerous substances such as asbestos have been found ... ... York, NY (PRWEB) December 6, 2009 -- As parents shop for ... reports of recalls due to lead paint or asbestos contamination, says ... visit hospital emergency rooms each year due to toy-related injuries,” says ...
(Date:12/5/2009)... Babies, This Type of Blood Cancer Is Most Challenging-- ... Pediatric oncologists have identified specific genes, dubbed partner ... often-fatal form of leukemia in infants. By more accurately ... which infants may benefit from particular treatments. ,, ...
(Date:12/5/2009)... of International Solutions, an innovative new international private medical insurance plan ... addition to offering customers the flexibility to add or remove a ... Solutions enables customers to tailor their benefits to complement those already ... ...
(Date:12/4/2009)... Thousands of KPMG LLP employees came together in more than ... event which combines the audit, tax and advisory firm,s support ... day reflects our firm,s long history of volunteerism. Instead of ... to brighten the holidays for some children," said Tim Flynn, ...
(Date:12/4/2009)... KANSAS CITY, Mo., Dec. 4 The large, two-day free ... (NAFC) in Kansas City on Wednesday and Thursday is not ... uninsured and has not seen a doctor recently. All participants ... ,, "Many people who attended the three previous large free ...
Breaking Medicine News(10 mins):Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Free Health Clinic Event Is Not Just for the Sick 2[0] Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season [0] New Gene Findings Will Help Guide Treatment in Infant Leukemia[0] AVIVA's Private Health Insurance Products Solutions Go International[0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children[0] Free Health Clinic Event Is Not Just for the Sick
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |